What If Doctors Could Heal Broken Genes? (Op-Ed)

Katrine Bosley is CEO, and Sandra Glucksmann COO, of Editas Medicine, a genome editing company targeting treatment of genetic diseases. The company was founded by pioneers in the field who have specific expertise in CRISPR/Cas9 and TALE technologies. World Economic Forum Technology Pioneers, class of 2015. The authors contributed this article to Live Science's Expert Voices: Op-Ed & Insights.